正在进行以添加第三种药物的研究，即静脉注射的前列腺素类花青素。
Studies are underway investigating the addition of a third agent, the intravenous prostanoid epoprostenol.
对于病人来说，疾病还没有得到良好的控制，目前正在进行有关第三种药物即静脉前列腺素类依前列醇的研究。
For patients whose disease is still not well-controlled, studies are underway investigating the addition of a third agent, the intravenous prostanoid epoprostenol.
一种可能的选择是米索前列醇的标示外使用，这是一种合成的前列腺素E1类似物，被核准用于防止和治疗胃肠道溃疡。
One possible option in this setting is the off-label use of misoprostol, a synthetic prostaglandin E1 analogue licensed for prevention and treatment of gastrointestinal ulcers.
一种可能的选择是米索前列醇的标示外使用，这是一种合成的前列腺素E1类似物，被核准用于防止和治疗胃肠道溃疡。
One possible option in this setting is the off-label use of misoprostol, a synthetic prostaglandin E1 analogue licensed for prevention and treatment of gastrointestinal ulcers.
应用推荐